Results 151 to 160 of about 14,473,613 (297)

Ropeginterferon‐α2b in mycosis fungoides and Sézary syndrome: Safety and efficacy in 41 patients

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Pegylated interferon‐α2a became the off‐label alternative for treating mycosis fungoides/Sézary syndrome (MF/SS) after non‐pegylated interferons were withdrawn. This study aimed to evaluate the safety and efficacy of ropeginterferon‐α2b in MF/SS. Patients and methods We performed a retrospective multicenter analysis at
Stefanie Porkert   +15 more
wiley   +1 more source

Outcome of patients supported with the HeartMate 3 after extracorporeal life support: On behalf of the Durable Mechanical Circulatory Support After Extracorporeal Life Support Study Group

open access: yes
Objectives: The Durable Mechanical Circulatory Support System After Extracorporeal Life Support registry is a multicenter registry of patients who were bridged from extracorporeal life support to a durable mechanical circulatory support system.
Albert, Alexander   +28 more
core  

Is It Time to Raise the Threshold for Critically Low Fibrinogen? Insights From a Retrospective, Consecutive‐Case Cohort Study of Low Fibrinogen due to Various Causes

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Fibrinogen deficiency is an important coagulation abnormality, with diverse causes. Methods A consecutive‐case cohort study of adult and pediatric patients with low Clauss fibrinogen at four acute care hospitals was undertaken to explore findings, causes, and predictors of outcomes, including the optimal fibrinogen critical value ...
Natalie Mathews   +7 more
wiley   +1 more source

Development of simulated and ovine models of extracorporeal life support to improve understanding of circuit-host interactions

open access: yes, 2012
Background: Extracorporeal life support (ECLS) is a life-saving technology that is being increasingly used in patients with severe cardiorespiratory failure. However, ECLS is not without risks.
Platts, David G.   +25 more
core  

Increased incidence and healthcare burden of bullous pemphigoid: A population‐based cohort study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Bullous pemphigoid prevalence in Germany has risen substantially, particularly among older adults, and is associated with increased comorbidity burden, threefold higher mortality and markedly greater healthcare utilization and costs. These findings highlight a growing clinical and economic burden in ageing populations requiring improved management ...
Anna C. Meyer   +9 more
wiley   +1 more source

Racial disparities in anaemia associated with paediatric chronic kidney disease

open access: yes
British Journal of Haematology, EarlyView.
Manya Raina   +3 more
wiley   +1 more source

The Goldilocks Principle in Neonatal Fluids: Finding the Just‐Right Balance

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT The impact of disrupted fluid balance on outcomes in critically unwell children and adults is well described. Recent literature in neonates has demonstrated that both fluid overload and excessive postnatal fluid losses are associated with increased morbidity and mortality.
Jane B. McMahon   +7 more
wiley   +1 more source

Pediatric Langerhans Cell Histiocytosis Presenting With Bilateral Parotid Gland Swelling and Cystic Lung Disease: A Case Report and Literature Review

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Langerhans cell histiocytosis (LCH) is a neoplastic process originating from immature myeloid precursor cells. In this report, we describe a case of a 17‐month‐old with scaling of the scalp and swelling of the bilateral parotid glands who developed acute respiratory distress.
Aretha On   +4 more
wiley   +1 more source

Extracorporeal Life Support (ECLS) for Pulmonary Vein Stenosis Interventions. [PDF]

open access: yesPediatr Cardiol
Tsoi SM   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy